A human body has several systems that need to work at its optimum level to ensure a healthy life quality. Unless all these systems harmonize to work together seamlessly, your body will come up with certain issues that cannot be eluded naturally. While most of the systems have a way of indicating their weakness, the nervous system may crash in the most unlikely hour. Many people often gloss over neural issues by considering severe pain as some form of cramp. Some neural diseases may come with serious symptoms too. However, as technology has developed to help people with their pain and related issues, fighting these serious neural problems has become a less complex process. Let us look at five new neurology technologies that have created a wave of effective cure to the searing sensations.
1. Hand-Held Nerve Stimulator
This is one of the most advanced technologies to fight the episodic cluster headaches. It comes in handy in situations where you are suffering from severe headache or pain in other parts above the neck. The first non-invasive, hand-held vagus nerve stimulator has been developed by gammaCore, a team primarily focusing on neural treatments.
This stimulator was issued and released by the FDA in April 2017. According to the ACT1 trials, around 34% of the patients experienced a decrease in headaches by using gammaCore. Therefore, it was approved for the next set of trials, after which the stimulator was accepted as the best technology ever made for the acute treatment of episodic cluster headaches in adults. Everyone experiencing such neural issues have to consult a doctor before using the stimulator. Although it is safe to use, a medical consultation is highly recommended. Once you are ready to use it, you only need to apply this stimulator’s pressure at the neck.
2. Genetic Health Risks Test
This is an FDA-authorized direct-to-consumer test that was approved in April 2017. It helps users check for about 10 genetic disorders in their bodies. Parkinson’s disease can be detected using this device, which tests for the GBA mutations and autosomal dominant LRRK2. Late-onset Alzheimer’s disease can also be easily detected with the tests for ApoE4. Any user can test for other health risks like celiac disease, early-onset primary dystonia, factor XI deficiency, hereditary hemochromatosis, G6PD deficiency, and hereditary thrombophilia.
3. Neurosurgery Tracking System
The StealthStation S8 Neurosurgery System was released in April 2017 by Medtronic. This equipment includes software for data processing, 3D cameras, related algorithms, and electromagnetic sensors that track the tools’ location. It has two touchscreen 27″ monitors like tablets and smartphones with wireless connectivity to the other devices in the hospital. This connection can be used to import and export exams from any department in the hospital.
4. Therapy System to Treat Depression
The FDA approved Neurostar’s TMS therapy system in April 2017. It helps treat patients with MDD; the effects may be most apparent in the patients who show an inadequate response to at least one antidepressant. Most of the TMS therapy sessions are completed in around 20 minutes. According to the real-world studies conducted with a TMS therapy system, 37% of patients achieved remission from MDD within 6 weeks.